John Fowler
2020
In 2020, John Fowler earned a total compensation of $1.3M as Chief Executive Officer at Kezar Life Sciences, a 64% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $243,789 |
|---|---|
| Option Awards | $463,900 |
| Salary | $546,000 |
| Other | $11,994 |
| Total | $1,265,683 |
Fowler received $546K in salary, accounting for 43% of the total pay in 2020.
Fowler also received $243.8K in non-equity incentive plan, $463.9K in option awards and $12K in other compensation.
Rankings
In 2020, John Fowler's compensation ranked 7,600th out of 13,090 executives tracked by ExecPay. In other words, Fowler earned more than 41.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,600 out of 13,090 | 42nd |
Division Manufacturing | 3,204 out of 5,624 | 43rd |
Major group Chemicals And Allied Products | 1,292 out of 2,257 | 43rd |
Industry group Drugs | 1,118 out of 1,957 | 43rd |
Industry Pharmaceutical Preparations | 834 out of 1,462 | 43rd |
Source: SEC filing on April 26, 2022.
Fowler's colleagues
We found two more compensation records of executives who worked with John Fowler at Kezar Life Sciences in 2020.